Novel immunotherapy against neuronal and brain tumors

Details for Australian Patent Application No. 2008281015 (hide)

Owner immatics biotechnologies GmbH

Inventors Weinschenk, Toni; Walter, Steffen; Schoor, Oliver; Singh, Harpreet; Trautwein, Claudia; Hilf, Norbert

Agent Pizzeys

Pub. Number AU-B-2008281015

PCT Pub. Number WO2009/015843

Priority 07014797.0 27.07.07 EP; 60/953,161 31.07.07 US; 08005889.4 27.03.08 EP

Filing date 25 July 2008

Wipo publication date 5 February 2009

Acceptance publication date 26 July 2012

International Classifications

C12N 9/16 Enzymes, e.g. ligases (6.) - acting on ester bonds (3.1)

A61K 39/00 Medicinal preparations containing antigens or antibodies

A61P 35/00 Antineoplastic agents

C07K 7/06 Peptides having 5 to 20 amino acids in a fully defined sequence

C07K 7/08 Peptides having 5 to 20 amino acids in a fully defined sequence

Event Publications

18 February 2010 PCT application entered the National Phase

  PCT publication WO2009/015843 Priority application(s): WO2009/015843

27 May 2010 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 09 Apr 2010

28 April 2011 Alteration of Name

  The name of the applicant has been altered to immatics biotechnologies GmbH

26 July 2012 Application Accepted

  Published as AU-B-2008281015

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008281016-Novel combinations of neramexane for the treatment of neurodegenerative disorders

2008281014-Novel immunogenic epitopes for immunotherapy